| Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer F Sato-Kaneko, S Yao, A Ahmadi, SS Zhang, T Hosoya, MM Kaneda, ... JCI insight 2 (18), 2017 | 268 | 2017 |
| Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections T Nanki, I Onoue, K Nagasaka, A Takayasu, M Ebisawa, T Hosoya, ... Annals of the rheumatic diseases 72 (6), 1100-1102, 2013 | 57 | 2013 |
| Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE) T Sugihara, T Ishizaki, T Hosoya, S Iga, W Yokoyama, F Hirano, ... Rheumatology 54 (5), 798-807, 2015 | 49 | 2015 |
| Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression T Hosoya, H Iwai, Y Yamaguchi, K Kawahata, N Miyasaka, H Kohsaka Annals of the rheumatic diseases 75 (1), 253-259, 2016 | 36 | 2016 |
| Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan S Oba, T Hosoya, M Amamiya, T Mitsumura, D Kawata, H Sasaki, ... Frontiers in Cardiovascular Medicine 8, 767074, 2021 | 32 | 2021 |
| Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study T Sugihara, T Ishizaki, W Onoguchi, H Baba, T Matsumoto, S Iga, K Kubo, ... Rheumatology 60 (9), 4252-4261, 2021 | 30 | 2021 |
| Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC) K Oku, T Atsumi, Y Akiyama, H Amano, N Azuma, T Bohgaki, YF Asanuma, ... Modern rheumatology 28 (4), 642-648, 2018 | 28 | 2018 |
| A case presenting with the clinical characteristics of tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) without TNFRSF1A mutations successfully treated … T Hosoya, F Mizoguchi, H Hasegawa, K Miura, R Koike, T Kubota, ... Internal Medicine 54 (16), 2069-2072, 2015 | 28 | 2015 |
| Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis K Kaneko, T Nanki, T Hosoya, F Mizoguchi, N Miyasaka Modern rheumatology 20 (6), 632-636, 2010 | 28 | 2010 |
| Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist T Hosoya, F Sato-Kaneko, A Ahmadi, S Yao, F Lao, K Kitaura, T Matsutani, ... Proceedings of the National Academy of Sciences 115 (29), E6836-E6844, 2018 | 23 | 2018 |
| Clinical significance of complement as a biomarker of disease activity in 4 cases of IgG4-related disease with retroperitoneal fibrosis M Kihara, T Sugihara, T Hosoya, N Miyasaka Clin Exp Rheumatol 31 (6), 947-949, 2013 | 16 | 2013 |
| CD34+THY1+ synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro S Noda, T Hosoya, Y Komiya, Y Tagawa, K Endo, K Komori, H Koga, ... Arthritis research & therapy 24 (1), 45, 2022 | 13 | 2022 |
| Acquired Gitelman syndrome in an anti-SSA antibody-positive patient with a SLC12A3 heterozygous mutation T Kusuda, T Hosoya, T Mori, K Ihara, H Nishida, M Chiga, E Sohara, T Rai, ... Internal Medicine 55 (21), 3201-3204, 2016 | 12 | 2016 |
| Identification of compounds that prolong type I interferon signaling as potential vaccine adjuvants NM Shukla, KI Arimoto, S Yao, JB Fan, Y Zhang, F Sato-Kaneko, FS Lao, ... SLAS DISCOVERY: Advancing Life Sciences R&D 23 (9), 960-973, 2018 | 10 | 2018 |
| Discovery of a novel microtubule targeting agent as an adjuvant for cancer immunotherapy F Sato-Kaneko, X Wang, S Yao, T Hosoya, FS Lao, K Messer, M Pu, ... BioMed research international 2018 (1), 8091283, 2018 | 10 | 2018 |
| Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts T Hosoya, T Saito, H Baba, N Tanaka, S Noda, Y Komiya, Y Tagawa, ... Rheumatology 61 (8), 3427-3438, 2022 | 8 | 2022 |
| Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity Y Mitsui, T Suzuki, K Kuniyoshi, J Inamo, K Yamaguchi, M Komuro, ... Immunity 56 (8), 1939-1954. e12, 2023 | 6 | 2023 |
| Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease F Kondo, T Sugihara, N Umezawa, H Hasegawa, T Hosoya, N Kimura, ... Arthritis Research & Therapy 24 (1), 92, 2022 | 6 | 2022 |
| Plasma levels of decorin increased in patients during the progression of breast cancer T Hosoya, G Oda, T Nakagawa, I Onishi, T Hosoya, M Ishiguro, T Ishikawa, ... Journal of Clinical Medicine 10 (23), 5530, 2021 | 6 | 2021 |
| Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19 T Hosoya, S Oba, Y Komiya, D Kawata, M Kamiya, H Iwai, S Miyamoto, ... Proceedings of the National Academy of Sciences 120 (22), e2300155120, 2023 | 5 | 2023 |
